Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Elanco Animal Health
(NYSE:ELAN)
Intraday
$13.26
0.22
[1.69%]
After-Hours
$13.26
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$13.26
0.22
[1.69%]
At close: Apr 26
$13.26
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 12 days from now on Wed May 8th, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Elanco Animal Health Stock (NYSE:ELAN)
Elanco Animal Health Stock (NYSE: ELAN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 09, 2024
FDA Approved Pradalex (Pradofloxacin Injection) Solution For Certain Respiratory Diseases In Cattle And Swine; Approves New Antimicrobial Drug For Cattle And Swine; Pradalex Is Sponsored By Elanco U.S.
Benzinga Newsdesk
-
Apr 9, 2024, 1:10PM
Monday, April 01, 2024
Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members
Vandana Singh
-
Apr 1, 2024, 8:45AM
Elanco Animal Health Has Appointed Two New Independent Directors, Kathy Turner And Craig Wallace, To Its Board Of Directors Effective Immediately, Expanding The Board To 14 Members
Benzinga Newsdesk
-
Apr 1, 2024, 6:37AM
Bloomberg Reported Late Sunday: Activist Investor Ancora Secures Two Elanco Board Seats
Charles Gross
-
Apr 1, 2024, 4:43AM
Tuesday, March 12, 2024
Piper Sandler Reiterates Neutral on Elanco Animal Health, Raises Price Target to $18
Benzinga Newsdesk
-
Mar 12, 2024, 10:08AM
Tuesday, February 27, 2024
Goldman Sachs Maintains Sell on Elanco Animal Health, Raises Price Target to $14
Benzinga Newsdesk
-
Feb 27, 2024, 11:17AM
Morgan Stanley Maintains Overweight on Elanco Animal Health, Raises Price Target to $17
Benzinga Newsdesk
-
Feb 27, 2024, 10:56AM
Breaking Down Elanco Animal Health: 6 Analysts Share Their Views
Benzinga Insights
-
Feb 27, 2024, 10:00AM
Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $19
Benzinga Newsdesk
-
Feb 27, 2024, 9:35AM
Monday, February 26, 2024
This Pet Health Company Sees Growing Demand For Farm-Animal Products, Cost Savings From Restructuring
Vandana Singh
-
Feb 26, 2024, 10:54AM
Elanco Animal Health shares are trading higher after the company reported mixed Q4 earnings and issued 2024 guidance.
Benzinga Newsdesk
-
Feb 26, 2024, 6:45AM
Elanco Animal Health Forecasts Fiscal Year 2024 Adjusted EPS Of $0.87-$0.95 Versus Consensus Of $0.89
Benzinga Newsdesk
-
Feb 26, 2024, 6:34AM
Elanco Animal Health Forecasts Fiscal Year 2024 Sales Of $4.45B-$4.54B Versus Consensus Of $4.51B
Benzinga Newsdesk
-
Feb 26, 2024, 6:34AM
Elanco Animal Health Announced Restructuring Impacting Approximately 420 Personnel, Resulting In A Charge To 2024 Reported Results Of $50M-$55M And Generating Approximately $30M-$35M In Annualized Savings
Benzinga Newsdesk
-
Feb 26, 2024, 6:32AM
Elanco Animal Health Q4 Adjusted EPS $0.08 Misses $0.11 Estimate, Sales $1.03B Beat $1.00B Estimate
Benzinga Newsdesk
-
Feb 26, 2024, 6:30AM
US Stocks Could Pause For Breather After Record Rally: Analyst Says 'No Doubt' That 2024 Shaping Up To 'Best Year Since 1999'
Shanthi Rexaline
-
Feb 26, 2024, 5:33AM
Earnings Scheduled For February 26, 2024
Benzinga Insights
-
Feb 26, 2024, 4:47AM
Friday, February 23, 2024
Earnings Outlook For Elanco Animal Health
Benzinga Insights
-
Feb 23, 2024, 9:01AM
Monday, February 05, 2024
Elanco Animal Health To Offload Aqua Business For $1.3B, Plans To Lower Debt Burden
Vandana Singh
-
Feb 5, 2024, 10:48AM
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
Avi Kapoor
-
Feb 5, 2024, 10:32AM
Elanco Animal Health shares are trading higher after the company announced the sale of its aqua business to Merck Animal health for $1.3 billion.
Benzinga Newsdesk
-
Feb 5, 2024, 9:15AM
Elanco Animal Health Has Agreed To Sell Its Aqua Business To Merck's Animal Health For Approximately $1.3 Billion In Cash, Which Represents Approximately 7.4x The Estimated 2023 Revenue Of The Elanco Aqua Business
Benzinga Newsdesk
-
Feb 5, 2024, 6:40AM
Wednesday, January 17, 2024
Goldman Sachs Maintains Sell Rating for Elanco Animal Health: Here's What You Need To Know
Benzinga Insights
-
Jan 17, 2024, 12:00PM
Goldman Sachs Maintains Sell on Elanco Animal Health, Raises Price Target to $12.5
Benzinga Newsdesk
-
Jan 17, 2024, 10:17AM
Monday, January 08, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Jan 8, 2024, 12:35PM
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 5, 2024, 1:13PM
Elanco Animal Health shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $13 to $20.
Benzinga Newsdesk
-
Jan 5, 2024, 10:56AM
Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Jan 5, 2024, 10:18AM
Analyst Expectations For Elanco Animal Health's Future
Benzinga Insights
-
Jan 5, 2024, 8:00AM
Stifel Upgrades Elanco Animal Health to Buy, Raises Price Target to $20
Benzinga Newsdesk
-
Jan 5, 2024, 7:59AM
Tuesday, January 02, 2024
Elanco Animal Health Announces Planned Board Leadership Changes And Corporate Governance Actions; Lawrence Kurzius To Become Next Chairman Of The Board
Benzinga Newsdesk
-
Jan 2, 2024, 8:41AM
Tuesday, December 19, 2023
Jefferies Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $17
Benzinga Newsdesk
-
Dec 19, 2023, 11:47AM
Friday, December 15, 2023
Reported December 14, 'Elanco Animal Health CEO Targeted By Activist Investor Ancora' - BNN Bloomberg
Benzinga Newsdesk
-
Dec 15, 2023, 1:00PM
Morgan Stanley Upgrades Elanco Animal Health to Overweight, Announces $16 Price Target
Benzinga Newsdesk
-
Dec 15, 2023, 5:40AM
Thursday, December 07, 2023
Stifel Maintains Hold on Elanco Animal Health, Raises Price Target to $13
Benzinga Newsdesk
-
Dec 7, 2023, 1:00PM
Analyst Expectations for Elanco Animal Health's Future
Benzinga Insights
-
Dec 7, 2023, 1:00PM
Tuesday, November 14, 2023
Elanco Animal Health shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $11 to $12.
Benzinga Newsdesk
-
Nov 14, 2023, 12:47PM
Monday, November 13, 2023
Piper Sandler Maintains Neutral on Elanco Animal Health, Raises Price Target to $12-Report released on 12th Nov 2023
Benzinga Newsdesk
-
Nov 13, 2023, 4:23PM
Piper Sandler Maintains Neutral on Elanco Animal Health, Raises Price Target to $12
Benzinga Newsdesk
-
Nov 13, 2023, 4:22PM
Wednesday, November 08, 2023
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $16-Report Released on 7th Nov
Benzinga Newsdesk
-
Nov 8, 2023, 4:52PM
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $16
Benzinga Newsdesk
-
Nov 8, 2023, 4:16PM
Tuesday, November 07, 2023
Fur-casting Success: Elanco Animal Health Tails Ahead with Raised Revenue Outlook, Stock Soars
Vandana Singh
-
Nov 7, 2023, 1:04PM
Elanco Animal Health shares are trading higher after the company reported strong Q3 results and raised its Fy23 guidance.
Benzinga Newsdesk
-
Nov 7, 2023, 11:23AM
Elanco Animal Health Q4 Outlook: Revenue Of $978M - $1.08B Vs. $1.01B Estimate; Adj. EPS Of $0.07 - $0.13 Vs. $0.10 Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 6:45AM
Elanco Animal Health Raises FY2023 Adj EPS Guidance from $0.80-$0.89 to $0.88 - $0.94 vs $0.85 Est; Raises FY2023 Sales Guidance from $4.35B-$4.41B to $4.36B - $4.40B vs $4.37B Est
Benzinga Newsdesk
-
Nov 7, 2023, 6:43AM
Elanco Animal Health Q3 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $1.07B Beat $1.04B Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 6:36AM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Thursday, November 02, 2023
Elanco Animal Health And Athian Collaborate To Transform Food Production Through Methane Reduction
Benzinga Newsdesk
-
Nov 2, 2023, 8:07AM
Monday, October 30, 2023
Stifel Maintains Hold Rating for Elanco Animal Health: Here's What You Need To Know
Benzinga Insights
-
Oct 30, 2023, 1:00PM
Stifel Maintains Hold on Elanco Animal Health, Lowers Price Target to $12
Benzinga Newsdesk
-
Oct 30, 2023, 11:05AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch